- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04341012
Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
March 29, 2022 updated by: Tushar Patel, Mayo Clinic
Development of a Breath Analysis Test for Disease Diagnosis and Prognosis
The purpose of the study is to develop a clinical test based on breath analysis that can be used for disease diagnosis or prognosis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study will seek to collect and analyze breath samples from a broad range of patients to develop reference ranges and to refine the testing methods.
Protocols for breath sample collection and algorithms for analysis will be developed.
Samples will be collected from normal volunteers, persons with documented liver disease, organ transplant or with known COVID-19 test results.
Study Type
Observational
Enrollment (Actual)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subjects who are undergoing evaluation and obtaining clinical care at Mayo Clinic in Florida will be enrolled
Description
Inclusion Criteria:
- Able to provide informed consent
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Normal
No known medical conditions
|
Analysis of volatile organic compounds in breath
|
Liver Cirrhosis
Clinically diagnosed with cirrhosis
|
Analysis of volatile organic compounds in breath
|
COVID-19 tested
Persons with known test results for COVID-19 RNA
|
Analysis of volatile organic compounds in breath
|
Other
Persons with other medical diagnosis, no known liver disease, negative for COVID-19
|
Analysis of volatile organic compounds in breath
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Breath volatile organic compound profiles
Time Frame: 1 day
|
Analysis of profiles of volatile organic compounds present in exhaled breath
|
1 day
|
Utility of breath profiles for disease diagnosis or prognosis
Time Frame: 14 days
|
Diagnosis or prognostic utility of breath volatile organic compound profiles
|
14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tushar Patel, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 10, 2019
Primary Completion (ACTUAL)
September 3, 2021
Study Completion (ACTUAL)
September 3, 2021
Study Registration Dates
First Submitted
April 7, 2020
First Submitted That Met QC Criteria
April 7, 2020
First Posted (ACTUAL)
April 10, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 31, 2022
Last Update Submitted That Met QC Criteria
March 29, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-001971
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Diseases
-
King's College Hospital NHS TrustSamsung MedisonRecruitingHepatitis | Liver Fat | NAFLD | Fibrosis, Liver | Liver Disease Chronic | Liver Steatoses | NASH With FibrosisUnited Kingdom
-
Beijing Chao Yang HospitalUnknownLiver Transplantation | End Stage Liver DIseaseChina
-
Beijing Friendship HospitalUnknownNonalcoholic Fatty Liver Disease | Liver Steatosis | Liver FibrosisChina
-
Shiraz University of Medical SciencesCompletedFatty Liver | Fatty Liver, NonalcoholicIran, Islamic Republic of
-
Beijing Continent Pharmaceutical Co, Ltd.RecruitingAcute-On-Chronic Liver Failure | Acute Liver FailureChina
-
Taipei City HospitalThe One Biopharmaceutical Co., Ltd.CompletedNon-alcoholic Fatty Liver Disease | Liver Fibrosis | Liver InjuryTaiwan
-
Chuncheon Sacred Heart HospitalSuspendedChronic Liver Disease | Acute Derangement of Liver FunctionKorea, Republic of
-
Institute of Liver and Biliary Sciences, IndiaCompletedAcute Liver FailureIndia
-
Assiut UniversityNot yet recruiting
-
Sheba Medical CenterEnrolling by invitation
Clinical Trials on Collection of breath sample
-
Emory UniversityMichael J. Fox Foundation for Parkinson's ResearchCompletedDefining a PD-specific Breath Fingerprint of Underlying Inflammatory and Neurodegenerative ProcessesParkinson's DiseaseUnited States
-
Landon Pediatric FoundationCompleted
-
Landon Pediatric FoundationCompletedBacterial InfectionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)TerminatedNonsmall Cell Lung Cancer Stage III | PneumonitisUnited States
-
Institut PasteurBiogroup Laboratoire de biologie médicaleRecruiting
-
GlaxoSmithKlineCompletedRespiratory DisordersUnited Kingdom
-
Jena University HospitalCompletedPneumonia, Ventilator-associatedGermany
-
Seoul National University HospitalUnknownGastrointestinal Hemorrhage | Volatile Organic CompoundsKorea, Republic of
-
Rambam Health Care CampusTechnion, Israel Institute of TechnologyCompletedParkinson's Disease | Parkinsonism
-
Stanford UniversityTerminated